Carmignac Gestion »

Royalty Pharma shares owned by Carmignac Gestion

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Carmignac Gestion from 13F filings

Historical chart of Carmignac Gestion investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Carmignac Gestion consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Carmignac Gestion

Quarter filed Position value Share count Share price at filing
2026-03-31 $30M 631k 47.97

More positions owned by Carmignac Gestion

NVIDIA Corporation (NVDA)
MercadoLibre (MELI)
S&p Global (SPGI)
Alphabet Cap Stk Cl A (GOOGL)
AmerisourceBergen (COR)
Amazon (AMZN)
McKesson Corporation (MCK)
Tradeweb Markets Cl A (TW)
Berkshire Hathaway CL B (BRK.B)
Block Cl A (XYZ)
Mastercard Cl A (MA)
salesforce (CRM)
Intercontinental Exchange (ICE)
Atlassian Corp Cl A (TEAM)
Broadcom (AVGO)

View all positions for Carmignac Gestion

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
BlackRock
FMR
Baillie Gifford & Co
Swedbank AB
State Street Corporation
Capital World Investors
Geode Capital Management
Adage Capital Partners GP
Caledonia
Vanguard Capital Management
Victory Capital Management
Northern Trust
Royal London Asset Management

View all funds holding Royalty Pharma